{"id":35228,"date":"2025-06-16T12:04:10","date_gmt":"2025-06-16T04:04:10","guid":{"rendered":"https:\/\/flcube.com\/?p=35228"},"modified":"2025-06-16T12:04:11","modified_gmt":"2025-06-16T04:04:11","slug":"cf-pharmtech-files-for-hong-kong-ipo-to-expand-respiratory-disease-treatments","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=35228","title":{"rendered":"CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments"},"content":{"rendered":"\n<p>China-based CF PharmTech, Inc., a specialist in inhalable drugs for respiratory diseases, has filed for an initial public offering (IPO) with the Hong Kong Stock Exchange. The filing was jointly sponsored by CITIC Securities and CMB International, with key financial terms remaining undisclosed at this stage.<\/p>\n\n\n\n<p><strong>Company Overview<\/strong><br>CF PharmTech focuses on the research, development, manufacturing, and commercialization of inhalable drugs targeting respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. Its core product, CF017 (budesonide suspension for inhalation), has rapidly penetrated the market since its approval in May 2021. It achieved 16% market share in China&#8217;s budesonide inhalation sector in 2024. Another product, GW006, received FDA approval in May 2024 for COPD treatment.<\/p>\n\n\n\n<p><strong>Financial Performance<\/strong><br>In 2024, CF PharmTech reported revenues of RMB 608 million (USD 85 million) and profits of RMB 21.09 million (USD 2.9 million), reflecting strong growth potential. The company allocated RMB 122 million (USD 17 million) to R&amp;D activities, underscoring its commitment to expanding its pipeline of over 20 inhalable drug candidates.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/sehk25061101384_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of sehk25061101384_c.\"><\/object><a id=\"wp-block-file--media-89982508-f159-4393-886c-532c0aa67976\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/sehk25061101384_c.pdf\">sehk25061101384_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/sehk25061101384_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-89982508-f159-4393-886c-532c0aa67976\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>China-based CF PharmTech, Inc., a specialist in inhalable drugs for respiratory diseases, has filed for&#8230;<\/p>\n","protected":false},"author":1,"featured_media":35231,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4154,72],"class_list":["post-35228","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-cf-pharmtech","tag-ipo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based CF PharmTech, Inc., a specialist in inhalable drugs for respiratory diseases, has filed for an initial public offering (IPO) with the Hong Kong Stock Exchange. The filing was jointly sponsored by CITIC Securities and CMB International, with key financial terms remaining undisclosed at this stage.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=35228\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments\" \/>\n<meta property=\"og:description\" content=\"China-based CF PharmTech, Inc., a specialist in inhalable drugs for respiratory diseases, has filed for an initial public offering (IPO) with the Hong Kong Stock Exchange. The filing was jointly sponsored by CITIC Securities and CMB International, with key financial terms remaining undisclosed at this stage.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=35228\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-16T04:04:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-16T04:04:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1602.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35228#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35228\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments\",\"datePublished\":\"2025-06-16T04:04:10+00:00\",\"dateModified\":\"2025-06-16T04:04:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35228\"},\"wordCount\":181,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35228#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/1602.webp\",\"keywords\":[\"CF PharmTech\",\"IPO\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=35228#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35228\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=35228\",\"name\":\"CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35228#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35228#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/1602.webp\",\"datePublished\":\"2025-06-16T04:04:10+00:00\",\"dateModified\":\"2025-06-16T04:04:11+00:00\",\"description\":\"China-based CF PharmTech, Inc., a specialist in inhalable drugs for respiratory diseases, has filed for an initial public offering (IPO) with the Hong Kong Stock Exchange. The filing was jointly sponsored by CITIC Securities and CMB International, with key financial terms remaining undisclosed at this stage.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35228#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=35228\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35228#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/1602.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/1602.webp\",\"width\":1080,\"height\":608,\"caption\":\"CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35228#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments - Insight, China&#039;s Pharmaceutical Industry","description":"China-based CF PharmTech, Inc., a specialist in inhalable drugs for respiratory diseases, has filed for an initial public offering (IPO) with the Hong Kong Stock Exchange. The filing was jointly sponsored by CITIC Securities and CMB International, with key financial terms remaining undisclosed at this stage.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=35228","og_locale":"en_US","og_type":"article","og_title":"CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments","og_description":"China-based CF PharmTech, Inc., a specialist in inhalable drugs for respiratory diseases, has filed for an initial public offering (IPO) with the Hong Kong Stock Exchange. The filing was jointly sponsored by CITIC Securities and CMB International, with key financial terms remaining undisclosed at this stage.","og_url":"https:\/\/flcube.com\/?p=35228","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-06-16T04:04:10+00:00","article_modified_time":"2025-06-16T04:04:11+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1602.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=35228#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=35228"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments","datePublished":"2025-06-16T04:04:10+00:00","dateModified":"2025-06-16T04:04:11+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=35228"},"wordCount":181,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=35228#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1602.webp","keywords":["CF PharmTech","IPO"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=35228#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=35228","url":"https:\/\/flcube.com\/?p=35228","name":"CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=35228#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=35228#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1602.webp","datePublished":"2025-06-16T04:04:10+00:00","dateModified":"2025-06-16T04:04:11+00:00","description":"China-based CF PharmTech, Inc., a specialist in inhalable drugs for respiratory diseases, has filed for an initial public offering (IPO) with the Hong Kong Stock Exchange. The filing was jointly sponsored by CITIC Securities and CMB International, with key financial terms remaining undisclosed at this stage.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=35228#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=35228"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=35228#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1602.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1602.webp","width":1080,"height":608,"caption":"CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=35228#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1602.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/35228","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=35228"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/35228\/revisions"}],"predecessor-version":[{"id":35232,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/35228\/revisions\/35232"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/35231"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=35228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=35228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=35228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}